Skip to main content
. 2024 Jul 15;15(7):922. doi: 10.3390/genes15070922

Table 2.

Sequencing data from the detected disease-associated microorganisms.

Patient Sample Type Pathogen Reads Contigs Coverage Depth
1 Serum Clostridium sp. 6554 1 0.8% 0.25×
2 Tempus E. coli 63 1 0.1% 0.005×
3 Whole blood DENV-2 72,078 3 99.8% 1145×
4 Whole blood E. coli 6939 1 0.1% 0.61×
5 Serum E. coli 10,968 1 0.3%
6 Whole blood HPgV 511 2 86.2% 41×
E. coli 4635 1 0.4% 0.18×
7 Streptococcus sp. 1347 1 0.1% 0.17×
Tempus E. coli 173 1 0.7% 0.012×
Serum E. coli 9889 1 0.1% 0.95×
8 Whole blood E. coli 5280 1 0.1% 0.41×
9 Serum HIV-1 52,420 2 92% 1805×
E. coli 13,778 1 0.2% 1.2×
10 Serum E. coli 22,622 1 0.1% 1.6×
11 Cerebrospinal fluid 1 E. coli 2084 1 0.1% 0.19×
Cerebrospinal fluid 2 E. coli 1703 1 0.2% 0.11×
12 Whole blood - - - - -
13 Negative control E. coli 27 0 - -